The Liver Meeting (TLM) 2025 is organized by American Association for the Study of Liver Diseases (AASLD) and will be held from Nov 07 - 11, 2025 at Walter E. Washington Convention Center, Washington, Dist of Col, United States of America.
No Matter Your Role in Hepatology—This Is Where You Belong
Whether you're a clinician, surgeon, researcher, trainee, advocate, academic, or policymaker — The Liver Meeting is where the global hepatology community comes together. With access to the latest breakthroughs in liver disease research, practical tools for patient care, and a powerful network of experts shaping the future of hepatology, the program offers something for everyone committed to improving liver health.
Engage, Learn, and Collaborate
Discover a dynamic lineup of expert-led sessions, workshops, and panels designed to advance your knowledge and skills in liver health. Our programming offers the latest research, clinical innovations, and practical tools to help you deliver exceptional patient care. Whether you’re a seasoned specialist or new to the field, there’s something to inspire and empower you at every stage of your professional journey.
Learning Objectives:
Upon completion of this activity, participants should be able to:
Accreditation and Designation Statements
CME Credit for Physicians
ACCME Accreditation Statement
The American Association for the Study of Liver Diseases is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation Statement
The American Association for the Study of Liver Diseases designates this other (live and online) activity for a maximum of 176.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 4.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and American Association for the Study of Liver Diseases. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Professions in scope for this activity are listed below.
Amedco Joint Accreditation Provider Number: 4008163
CME Session Credits
Please click on the link to see the list of CE credits awarded for each of the different sessions offered at TLM 2025.
Other Healthcare Providers
Pharmacists & Pharmacy Technicians
Amedco LLC designates this activity for a maximum of 26.75 knowledge-based CPE contact hours.
NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 45 days of your participation in the activity to meet the deadline for submission to CPE Monitor. Credits are generally reported during the first week of each month for those who claimed during the month prior.
Nurses
Amedco LLC designates this activity for a maximum of 26.75 ANCC contact hours.
Other Professions
Nurse Pharmacology
This activity is eligible for up to 18.50 pharmacotherapeutic hours. Please note onsite agenda for identification of sessions eligible for pharmacotherapeutic hours and self-submit those to your board.
Other Advanced Providers
The AAPA, ANCC and AANP accept reports from advanced practitioners of their participation in activities offering AMA PRA Category 1 CreditsTM for continuing education and credentialing purposes. For more information, please contact the appropriate organization.
Copyrights © 2026 eMedEvents Corporation, All Rights Reserved